ATP acts as a survival signal and prevents the mineralization of aortic valve

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 5, 2012, Pages 1191-1202

  Côté, Nancy ^a   El Husseini, Diala ^a   Pépin, Andrée ^a   Guauque Olarte, Sandra ^a   Ducharme, Valérie ^a   Bouchard Cannon, Pascale ^a   Audet, Audrey ^a   Fournier, Dominique ^a   Gaudreault, Nathalie ^a   Derbali, Habib ^a   McKee, Marc D ^c   Simard, Chantale ^b   Després, Jean Pierre ^a,b   Pibarot, Philippe ^a   Bossé, Yohan ^a,b   Mathieu, Patrick ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Aortic stenosis; ATP; Calcific aortic valve disease; Ectonucleotidase; ENPP1; Mineralization; P2Y 2 receptor; PI3K

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; CALCIUM; NUCLEOTIDASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE; PROTEIN ENPP1; PROTEIN KINASE B; PURINERGIC P2Y2 RECEPTOR; UNCLASSIFIED DRUG;

AORTA VALVE DISEASE; APOPTOSIS; ARTICLE; CALCIFIC AORTIC VALVE DISEASE; CELL SURVIVAL; CONTROLLED STUDY; ENPP1 GENE; GENE; GENETIC ASSOCIATION; GENOTYPE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; MICRO-COMPUTED TOMOGRAPHY; MICROARRAY ANALYSIS; MINERALIZATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VALVULAR INTERSTITIAL CELL;

ADENOSINE TRIPHOSPHATE; AORTIC VALVE; APOPTOSIS; CALCINOSIS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PYROPHOSPHATASES; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2Y; SIGNAL TRANSDUCTION; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; TISSUE ARRAY ANALYSIS;

EID: 84859652051     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.02.003     Document Type: Article

References (37)

1. Rajamannan N.M. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol 2009, 29:162-168.
2. Freeman R.V., Otto C.M. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005, 111:3316-3326.
3. Otto C.M. Calcific aortic stenosis-time to look more closely at the valve. N Engl J Med 2008, 359:1395-1398.
4. Towler D.A. Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype. Arterioscler Thromb Vasc Biol 2005, 25:651-654.
5. Goding J.W., Grobben B., Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 2003, 1638:1-19.
6. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008, 1783:673-694.
7. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
8. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
9. Li Y., Willer C.J., Ding J., Scheet P., Abecasis G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010, 34:816-834.
10. Goding J.W. Ecto-enzymes: physiology meets pathology. J Leukoc Biol 2000, 67:285-311.
11. Stefan C., Jansen S., Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 2005, 30:542-550.
12. Bollen M., Gijsbers R., Ceulemans H., Stalmans W., Stefan C. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 2000, 35:393-432.
13. Levesque S.A., Lavoie E.G., Lecka J., Bigonnesse F., Sevigny J. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 2007, 152:141-150.
14. Clair T., Lee H.Y., Liotta L.A., Stracke M.L. Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem 1997, 272:996-1001.
15. Rutsch F., Vaingankar S., Johnson K., Goldfine I., Maddux B., Schauerte P., et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001, 158:543-554.
16. Johnson K., Pritzker K., Goding J., Terkeltaub R. The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles. J Rheumatol 2001, 28:2681-2691.
17. Orriss I.R., Utting J.C., Brandao-Burch A., Colston K., Grubb B.R., Burnstock G., et al. Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate. Endocrinology 2007, 148:4208-4216.
18. Osman L., Chester A.H., Amrani M., Yacoub M.H., Smolenski R.T. A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin. Circulation 2006, 114:I566-I572.
19. Burnstock G., Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 2000, 295:862-869.
20. Lazarowski E.R., Boucher R.C., Harden T.K. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003, 64:785-795.
21. Erb L., Liao Z., Seye C.I., Weisman G.A. P2 receptors: intracellular signaling. Pflugers Arch 2006, 452:552-562.
22. Duronio V. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 2008, 415:333-344.
23. Arthur D.B., Georgi S., Akassoglou K., Insel P.A. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival. J Neurosci 2006, 26:3798-3804.
24. Sale E.M., Sale G.J. Protein kinase B: signalling roles and therapeutic targeting. Cell Mol Life Sci 2008, 65:113-127.
25. Sorenson C.M. Bcl-2 family members and disease. Biochim Biophys Acta 2004, 1644:169-177.
26. Mazumder S., Plesca D., Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 2008, 414:13-21.
27. Spoto B., Testa A., Parlongo R.M., Tripepi G., Trischitta V., Mallamaci F., et al. Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. Nephrol Dial Transplant 2012, 27:661-666.
28. Valli-Jaakola K., Suviolahti E., Schalin-Jantti C., Ripatti S., Silander K., Oksanen L., et al. Further evidence for the role of ENPP1 in obesity: association with morbid obesity in Finns. Obesity (Silver Spring) 2008, 16:2113-2119.
29. Keene K.L., Mychaleckyj J.C., Smith S.G., Leak T.S., Perlegas P.S., Langefeld C.D., et al. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes 2008, 57:1057-1062.
30. Lorenz-Depiereux B., Schnabel D., Tiosano D., Hausler G., Strom T.M. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 2010, 86:267-272.
31. Nitschke Y., Weissen-Plenz G., Terkeltaub R., Rutsch F. Npp1 promotes atherosclerosis in ApoE knockout mice. J Cell Mol Med 2011, 15:2273-2283.
32. Mohty D., Pibarot P., Despres J.P., Cote C., Arsenault B., Cartier A., et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol 2008, 28:187-193.
33. Johnson K., Hashimoto S., Lotz M., Pritzker K., Goding J., Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001, 44:1071-1081.
34. Schuchardt M., Tolle M., Prufer J., Prufer N., Huang T., Jankowski V., et al. Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification. Kidney Int 2012, 81:256-265.
35. Hoebertz A., Arnett T.R., Burnstock G. Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 2003, 24:290-297.
36. Hashimoto S., Ochs R.L., Rosen F., Quach J., McCabe G., Solan J., et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A 1998, 95:3094-3099.
37. Yip C.Y., Chen J.H., Zhao R., Simmons C.A. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 2009, 29:936-942.